DeutschNewstral
Article
wkrg.com on 2016-05-25 16:37
FDA delays high-stakes decision on muscular dystrophy drug
Related news
FDA delays decision on muscular dystrophy drugThe Salt Lake Tribune
FDA approves first muscular dystrophy drugreviewjournal.com
FDA tentatively approves first drug for muscular dystrophyMerced Sun-Star
In surprise decision, US approves muscular dystrophy drugabqjournal.com
Muscular Dystrophy Day at the FDAwsj.com- FDA tentatively OKs first muscular dystrophy drugThe Salt Lake Tribune
- Muscular Dystrophy Drugs Face New FDA Questionswsj.com
FDA tentatively approves 1st drug for muscular dystrophyThe Vindicator- MSarepta stock drops after Muscular Dystrophy study halted by FDAmarketwatch.com
FDA committee votes against approval of controversial muscular dystrophy drugWashington Post
NH family hopeful after FDA approves muscular dystrophy drugWMUR 9- HFDA Rejects Muscular Dystrophy Drug, Says It Doesn’t Workhamodia.com
FDA rejects muscular dystrophy drug, says it doesn't workljworld.com
FDA approves drug Exondys 51 to treat Duchenne muscular dystrophytriblive.com
FDA delays decision on e-cigarettes from vaping giant JuulSeattle Times- Coraopolis teen left in limbo by FDA inaction on muscular dystrophy treatmenttriblive.com
- MSarepta stock surges more than 20% as FDA finally OKs muscular dystrophy drugmarketwatch.com
- BSarepta Therapeutics Stock Sinks as FDA Questions Newest Muscular Dystrophy Drugbarrons.com